Insulinoma: pathophysiology, localization and management.

Insulinoma is a rare neuroendocrine tumor that causes oversecretion of insulin and, as a result, patients present with symptoms of hypoglycemia. Fortunately, insulinomas are usually benign and solitary, and surgical cure rates are highly favorable. Most of these tumors occur sporadically, but they can also be associated with multiple endocrine neoplasia type-1 syndrome. The diagnosis is confirmed by a supervised fast, and early detection is important. Several preoperative and intraoperative techniques with various success rates have been employed in order to localize the lesion. When technically feasible, tumor enucleation is the procedure of choice; however, a more formal resection may be necessary for certain tumors. In the age of laparoscopy, the role of laparoscopic surgery in the management of insulinomas is continuing to attract attention. This review will discuss the historical background, pathogenesis, diagnosis, localization and management of insulinomas.

[1]  S. Libutti,et al.  Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1. , 2009, Cancer research.

[2]  H. Moch,et al.  Insulinomatosis: A Multicentric Insulinoma Disease that Frequently Causes Early Recurrent Hyperinsulinemic Hypoglycemia , 2009, The American journal of surgical pathology.

[3]  A. Lim,et al.  Laparoscopic management of insulinomas , 2009, The British journal of surgery.

[4]  Douglas B. Evans,et al.  Treatment options for metastatic neuroendocrine tumors. , 2008, Surgery.

[5]  D. Metz,et al.  Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. , 2008, Gastroenterology.

[6]  G. Callender,et al.  Multiple endocrine neoplasia syndromes. , 2008, The Surgical clinics of North America.

[7]  V. Deshpande,et al.  Improved Contemporary Surgical Management of Insulinomas: A 25-year Experience at the Massachusetts General Hospital , 2008, Annals of surgery.

[8]  L. Way,et al.  Laparoscopic enucleation of insulinomas. , 2007, Archives of surgery.

[9]  F. Zeinali,et al.  Endoscopic ultrasonography (EUS) in the localization of insulinoma , 2007, Endocrine.

[10]  S. Choi,et al.  LOCALIZATION AND SURGICAL TREATMENT OF THE PANCREATIC INSULINOMAS , 2006, ANZ journal of surgery.

[11]  L. Hunyady,et al.  Menin and its interacting proteins: elucidation of menin function , 2006, Trends in Endocrinology & Metabolism.

[12]  F. Collins,et al.  Menin molecular interactions: insights into normal functions and tumorigenesis. , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[13]  C. Tschahargane,et al.  Malignant Metastatic Insulinoma—Postoperative Treatment and Follow-up , 2005, World Journal of Surgery.

[14]  P. Rochaix,et al.  Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. , 2005, European journal of endocrinology.

[15]  E. Krenning,et al.  Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  E. Finlayson,et al.  Surgical treatment of insulinomas. , 2004, The Surgical clinics of North America.

[17]  L. Kvols,et al.  Peptide Receptor Radionuclide Therapy , 2004, Annals of the New York Academy of Sciences.

[18]  R. Schlinkert,et al.  Laparoscopic localization and resection of insulinomas. , 2004, Archives of surgery.

[19]  P. Tam,et al.  Surgical treatment of pancreatic insulinomas in the era of laparoscopy , 2004, Surgical Endoscopy And Other Interventional Techniques.

[20]  J. Norton,et al.  Aggressive surgery for metastatic liver neuroendocrine tumors. , 2003, Surgery.

[21]  F. Collins,et al.  Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism. , 2003, Cancer research.

[22]  J. Bertherat,et al.  Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study. , 2003, The Journal of clinical endocrinology and metabolism.

[23]  S. Libutti,et al.  Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure. , 2002, Journal of the American College of Surgeons.

[24]  B. Ponder,et al.  Guidelines for diagnosis and therapy of MEN type 1 and type 2. , 2001, The Journal of clinical endocrinology and metabolism.

[25]  John P. Bilezikian,et al.  CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2 , 2001 .

[26]  F. Collins,et al.  A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Kazemier,et al.  Laparoscopic detection and resection of insulinomas. , 2000, Surgery.

[28]  S. Libutti,et al.  Forty-eight-hour fast: the diagnostic test for insulinoma. , 2000, The Journal of clinical endocrinology and metabolism.

[29]  R. Walsh,et al.  Preoperative localization of insulinomas is not necessary. , 1999, Journal of the American College of Surgeons.

[30]  O. Clark,et al.  Localization of insulinomas. , 1999, Archives of surgery.

[31]  B. Boehm,et al.  Loss of wild-type MEN1 gene expression in multiple endocrine neoplasia type 1-associated parathyroid adenoma. , 1999, Endocrine journal.

[32]  S. Libutti,et al.  Operative management of islet-cell tumors arising in the head of the pancreas. , 1998, Surgery.

[33]  Q. Duh,et al.  Insulinoma--experience from 1950 to 1995. , 1998, The Western journal of medicine.

[34]  Kester,et al.  Identification and characterization of the multiple endocrine neoplasia type 1 (MEN1) gene , 1998, Journal of internal medicine.

[35]  S. Libutti,et al.  Intraarterial calcium stimulation and intraoperative ultrasonography in the localization and resection of insulinomas. , 1997, Surgery.

[36]  G. Gill,et al.  Diazoxide treatment for insulinoma: a national UK survey. , 1997, Postgraduate medical journal.

[37]  S. Fan,et al.  Pancreatic Insulinomas: A 15-Year Experience , 1997 .

[38]  Y Wang,et al.  Positional cloning of the gene for multiple endocrine neoplasia-type 1. , 1997, Science.

[39]  M. Gagner,et al.  Early experience with laparoscopic resections of islet cell tumors. , 1996, Surgery.

[40]  Grant Cs.  Gastrointestinal endocrine tumours. Insulinoma. , 1996, Bailliere's clinical gastroenterology.

[41]  T. Frieling,et al.  Prospective study on the detection of insulinomas by endoscopic ultrasonography. , 1996, Endoscopy.

[42]  J. Norton,et al.  Plasma proinsulin-like component in insulinoma: a 25-year experience. , 1995, The Journal of clinical endocrinology and metabolism.

[43]  D. Fraker,et al.  Localization of Insulinomas to Regions of the Pancreas by Intra-arterial Stimulation with Calcium , 1995, Annals of Internal Medicine.

[44]  N. Sata,et al.  Malignant insulinoma causing liver metastasis 8 years after the initial surgery: Report of a case , 1995, Surgery Today.

[45]  F. Service,et al.  Surgical management of insulinoma associated with multiple endocrine neoplasia type I , 1994, World Journal of Surgery.

[46]  P. Maton.  Use of octreotide acetate for control of symptoms in patients with islet cell tumors , 1993, World journal of surgery.

[47]  J. Rastad,et al.  Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes , 1992, World Journal of Surgery.

[48]  C. Lightdale,et al.  Localization of pancreatic endocrine tumors by endoscopic ultrasonography. , 1992, The New England journal of medicine.

[49]  W. Lees,et al.  Endoscopic ultrasound for localisation of islet cell tumours. , 1992, Gut.

[50]  J. Norton,et al.  Results of a prospective strategy to diagnose, localize, and resect insulinomas. , 1991, Surgery.

[51]  D. Klonoff,et al.  Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach. , 1991, Surgery.

[52]  D. Ballard,et al.  Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. , 1991, Mayo Clinic proceedings.

[53]  J. Norton,et al.  Localization and surgical treatment of occult insulinomas. , 1990, Annals of surgery.

[54]  Maton Pn.  The use of the long-acting somatostatin analogue, octreotide acetate, in patients with islet cell tumors , 1989 .

[55]  W. Lems,et al.  Malignant insulinoma: is combined treatment with verapamil and the long-acting somatostatin analogue octreotide (SMS 201-995) more effective than single therapy with either drug? , 1989, The Netherlands journal of medicine.

[56]  R. Jensen,et al.  Use of long-acting somatostatin analog SMS 201-995 in patients with pancreatic islet cell tumors , 1989, Digestive Diseases and Sciences.

[57]  A. Vinik,et al.  Insulin-producing islet cell tumors. , 1989, Endocrinology and metabolism clinics of North America.

[58]  J. Charboneau,et al.  Insulinoma: the value of intraoperative ultrasonography. , 1988, Wiener klinische Wochenschrift.

[59]  C. Larsson,et al.  Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma , 1988, Nature.

[60]  L. Kvols,et al.  Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995). , 1987, Annals of internal medicine.

[61]  J. Farndon,et al.  Diazoxide in the management of patients with insulinoma , 1986, World Journal of Surgery.

[62]  Y. Okada,et al.  Medical treatment for inoperable insulinoma: clinical usefulness of diphenylhydantoin and diltiazem. , 1986, Japanese journal of clinical oncology.

[63]  J. Ulbrecht,et al.  Insulinoma in a 94-year-old Woman: Long-term Therapy with Verapamil , 1986, Diabetes Care.

[64]  P. Gorden,et al.  Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery. , 1984, Surgery.

[65]  Z. Laron,et al.  Evidence for a therapeutic effect of dl-propranolol in benign and malignant insulinoma: report of three cases , 1983, Journal of endocrinological investigation.

[66]  A. Kurtz,et al.  IS PREOPERATIVE LOCALISATION OF INSULINOMAS NECESSARY? , 1981, The Lancet.

[67]  E. Kaplan,et al.  Calcium Infusion: A New Provocative Test for Insulinomas , 1979, Annals of surgery.

[68]  L. Orci,et al.  Somatostatinoma syndrome. Biochemical, morphologic and clinical features. , 1979, The New England journal of medicine.

[69]  F. Service,et al.  The Surgical Aspects of Insulinomas , 1979, Annals of surgery.

[70]  D. Aderka,et al.  Suppression of hypoglycemic attacks and insulin release by propranolol in a patient with metastatic malignant insulinoma. , 1977, Diabete & metabolisme.

[71]  P. Sheedy,et al.  Preoperative angiographic localization of insulin-producing tumors of the pancreas. , 1975, The American journal of roentgenology, radium therapy, and nuclear medicine.

[72]  A. Basoli,et al.  Beta-islet cell tumors of the pancreas: results of a study on 1,067 cases. , 1974, Surgery.

[73]  A. Knudson.  Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[74]  S. Fajans,et al.  FURTHER STUDIES ON DIAZOXIDE SUPPRESSION OF INSULIN RELEASE FROM ABNORMAL AND NORMAL ISLET TISSUE IN MAN * , 1968, Annals of the New York Academy of Sciences.

[75]  F. Wolff.  Clinical and Physiological Implications of Diabetes Induced by Benzothiadiazines , 1964, Diabetes.

[76]  Foss Mv.  CARDIAC ARREST AND ADRENALINE. , 1964 .

[77]  P. Wermer.  ENDOCRINE ADENOMATOSIS AND PEPTIC ULCER IN A LARGE KINDRED. INHERITED MULTIPLE TUMORS AND MOSAIC PLEIOTROPISM IN MAN. , 1963, The American journal of medicine.

[78]  A. O. Whipple.  Islet cell tumors of the pancreas. , 1952, Canadian Medical Association journal.

[79]  V. K. Frantz,et al.  ADENOMA OF ISLET CELLS WITH HYPERINSULINISM: A REVIEW. , 1935, Annals of surgery.

[80]  W. L. Robinson,et al.  DYSINSULINISM: CONVULSIONS AND COMA DUE TO ISLET CELL TUMOR OF THE PANCREAS, WITH OPERATION AND CURE , 1929 .

[81]  H. E. Robertson,et al.  CARCINOMA OF THE ISLANDS OF THE PANCREAS: HYPERINSULINISM AND HYPOGLYCEMIA , 1927 .

[82]  C. Best.  The internal secretion of the pancreas. , 1922, Canadian Medical Association journal.

[83]  S. Libutti,et al.  A prospective evaluation of laparoscopic exploration with intraoperative ultrasound as a technique for localizing sporadic insulinomas. , 2005, Surgery.

[84]  E. Rubin.  Hypoglycemic disorders. , 1995, The New England journal of medicine.

[85]  F. Menegaux,et al.  Pancreatic insulinomas. , 1993, American journal of surgery.

[86]  J. Norton,et al.  Insulinomas: localization with selective intraarterial injection of calcium. , 1991, Radiology.

[87]  P. Maton.  The use of the long-acting somatostatin analogue, octreotide acetate, in patients with islet cell tumors. , 1989, Gastroenterology clinics of North America.

[88]  S. Fajans,et al.  Diagnosis and medical management of insulinomas. , 1979, Annual review of medicine.